Atlas Trials

Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients

Clinical trial NCT01784523 · TERMINATED

Trial details

NCT number
NCT01784523
Sponsor
Hospital for Special Surgery, New York
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Antiphospholipid Syndrome
Start date
2013-02-01
Primary completion
2015-09-30
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.